Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2026 07:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver...
May 22, 2026 07:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

– Phase 2 study in cholestatic liver diseases, focused on PBC and PSC, anticipated to initiate in Q1 2027 –– Builds on completed Phase 1a study and ongoing development in HDV – SOUTH SAN FRANCISCO,...
May 14, 2026 15:30 ET | Source: Custom Market Insights

[Latest] Global Dental Collagen Membranes Market Size/Share Worth USD 0.86 Billion by 2035 at a 7.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 15, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Dental Collagen Membranes Market Size, Trends and Insights By Source (Bovine...
May 13, 2026 08:30 ET | Source: Custom Market Insights

[Latest] Global Intravenous (IV) Fluid Bags Market Size/Share Worth USD 5.46 Billion by 2035 at a 6.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 13, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Intravenous (IV) Fluid Bags Market Size, Trends and Insights By Material Type (PVC...
May 13, 2026 02:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026

SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases,...
May 12, 2026 09:00 ET | Source: Soaring Aerospace

Soaring Showcases Autonomous Aerial Medical Resupply Capability During U.S. Army XVIII Airborne Corps 44th Medical Brigade Operational Validation

ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Soaring, a leader in autonomous aerial logistics for contested environments, today announced its participation in the U.S. Army XVIII Airborne Corps...
May 12, 2026 04:30 ET | Source: Custom Market Insights

[Latest] Global Clinical Informatics Market Size/Share Worth USD 962.41 Billion by 2035 at a 13.36% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Clinical Informatics Market Size, Trends and Insights By Type (Electronic Health...
May 11, 2026 08:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases,...
May 08, 2026 07:30 ET | Source: Custom Market Insights

[Latest] Global Surgical Case Carts Market Size/Share Worth USD 686.99 Million by 2035 at a 4.04% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 08, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Surgical Case Carts Market Size, Trends and Insights By Type (Open Case Cart,...
May 07, 2026 16:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

– Completed Phase 1b studies for ABI-5366 and ABI-1179, helicase-primase inhibitors for recurrent genital herpes – – Completed chronic toxicology studies for ABI-6250, an oral small-molecule entry...